The University of Pennsylvania Health System (Penn Medicine) has started construction on a four-storey, 162,000ft2 multispecialty outpatient facility in Montgomeryville.
The new centre, dubbed Penn Medicine Montgomeryville, is strategically located at 200 DeKalb Pike in North Wales, Montgomery County, and is scheduled to open in late 2027.
Entailing a $27m investment, the facility aims to enhance patient care options in Montgomery and Bucks counties, with a focus on advanced services such as cancer care.
Penn Medicine Montgomeryville will provide comprehensive cancer care through the Abramson Cancer Center, offering radiation oncology and chemotherapy.
It will also house services in primary care, heart and vascular, orthopaedics, neuroscience, women’s health, and surgical consultations, ensuring a wide range of medical support.
University of Pennsylvania Health System CEO Kevin Mahoney said: “By bringing advanced, lifesaving services closer to patients, especially those undergoing cancer therapy that can last for months, we’re not just enhancing accessibility, we’re transforming the entire treatment journey.
“Penn Medicine Montgomeryville will make getting care easier for patients, while reimagining how treatments should be delivered and experienced.”
The new facility aims to streamline patient access to multiple specialists in a single visit, promoting convenience and comprehensive care.
It will also provide support services, including advanced imaging, laboratory services, infusion therapy, and a retail pharmacy, enhancing the overall patient experience.
The first floor will feature registration services, imaging, and radiation oncology, while upper floors will accommodate various specialties, with scope for future expansion.
Penn Medicine aims to pursue LEED Gold certification for the building.
The facility is designed to have natural lighting and therapeutic views of native plant-filled meadows to enhance patient and staff environments.
Its specialised bird-safe glass and low-carbon concrete will minimise the environmental impact, supporting local wildlife and reducing the project’s carbon footprint.
Also, it is designed to reduce operational carbon emissions by 50% by 2030, to achieve net-zero emissions by 2042.
A 530-ton geothermal system will serve as the primary energy source, and the building will operate on a 100% electric platform, reducing energy usage and reliance on fossil fuels.
